News
thumbnail
Global MarketsAZ’s Beyfortus authorized as first RSV treatment in ChinaAZ’s Beyfortus authorized as first RSV treatment in China
China has authorized the use of AstraZeneca and Sanofi’s Beyfortus (nirsevimab) as a preventative treatment against respiratory syncytial virus (RSV) in newborns.